Transforming the future of clinical development


Digital R&D

Transforming the future of clinical development

Biopharma R&D has changed the face of disease management over the years. Yet many in the field admit that clinical development has fallen behind in adopting digital technologies, which have the potential to change how research organizations can engage with patients, innovate in patient care, and execute processes to drive efficiencies. While digital transformation is a complex, resource-intensive, and lengthy undertaking, the rewards are well worth the effort.

Digital technologies provide opportunities to:

  • Engage effectively with patients and investigators through targeted, omni-channel interactions to meet their needs and foster loyal relationships
  • Innovate by catalyzing the development of products and services to drive value for patients, health care providers, and payers using data and innovative platforms such as digital endpoints, real-world evidence, and telemedicine
  • Execute efficiently by digitizing and rationalizing processes to drive efficiencies, cycle time reductions, and cost savings

Looking at digital through this lens can help shift the focus from individual technologies and solutions to how these technologies collectively can help accomplish bigger clinical development objectives and identify strategic opportunities that a narrow technology-centric view might miss.

Did you find this useful?